CSBR
HealthcareChampions Oncology, Inc.
$6.71
+$0.05 (+0.75%)
Jan 5, 2026
Price History (1Y)
Analysis
Champions Oncology, Inc. is a biotechnology company in the healthcare sector, with a market capitalization of $93.18 million and 213 employees. The company operates within the biotechnology industry, which involves the use of biological systems to develop new products and technologies. The financial health of Champions Oncology, Inc. shows mixed results. On one hand, the company has achieved profitability, with gross margin at 50.1%, operating margin at 1.2%, and profit margin at 4.3%. Additionally, returns on equity and assets stand at 98.9% and 5.6%, respectively. However, the debt-to-equity ratio is high at 127.91, indicating a significant level of indebtedness. The company's balance sheet also shows $8.52 million in cash and $5.41 million in debt. The valuation context for Champions Oncology, Inc. indicates that the company trades at a premium to its peers. With a price-to-earnings (P/E) ratio of 39.47 and forward P/E of 67.10, the stock appears to be relatively expensive compared to its historical performance. The revenue growth rate has been steady, with an increase of 11.5% year-over-year, while earnings growth has declined by 61.1%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Champions Oncology, Inc.
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Visit website →Key Statistics
- Market Cap
- $93.18M
- P/E Ratio
- 39.47
- 52-Week High
- $11.99
- 52-Week Low
- $5.59
- Avg Volume
- 15.19K
- Beta
- 0.35
Company Info
- Industry
- Biotechnology
- Exchange
- NCM
- Country
- United States
- Employees
- 213